First results of the register of patients with osteoporosis included in the secondary fracture prevention services

Background. To reduce the number of osteoporotic fractures in the world in recent years, — Fracture Liaison Service has been created. Since 2019, the development of a register of patients included in the Secondary Fracture Prevention named «Prometheus» has begun in Russia.

Materials and methods. An information system for storing, searching and processing information has been created, and a registration card has been developed. Six FLS participate in the register management. As of 10.03.2021, data on 387 patients were introduced in the register.

Results. Among the included patients, 46.25% received a fracture of the proximal femur, 20.41% — of the vertebral bodies and 16.80% of the proximal humerus, the rest had fractures of other localizations. The risk of fractures was assessed in all patients. A high risk of major osteoporotic fractures according to FRAX was determined in 160 (43.24%) people. Two-energy X-ray absorptiometry (DXA) was performed in 152 (39.28%) patients, and osteoporosis was detected in 103 (67.76%), osteopenia — in 42 (27.63%) patients. The risk of falls was assessed in 100% of the included patients, and the risk of falls was determined to be high in 343 (88.63%) patients. Evaluation of various laboratory parameters to find the causes of secondary osteoporosis was performed in most patients. After consultation with the FLS doctor, anti-osteoporotic drugs were prescribed to 241 (64.27%) people. Among the rest, 70 (52.24%) patients had contra-indications and 31 (23.13%) people needed further examination.

Conclusions. Thus, the use of the register allows you to evaluate all the main sections of the organization of assistance within the FLS and compare them with international standards to identify «gaps» and improve the work of the service.

1. Lesnyak OM. Audit sostoyaniya problemy osteoporoza v stranah Vostochnoj Evropy i Central'noj Azii v 2010 godu. Osteoporoz i osteopatii. 2011; 2: 3-6.

2. Ganda K., Puech M., Chen J.S. et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2013; 24(2): 349-406. https://doi.org/10.1007/s00198-012-2090-y

3. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17: 1726-1733. https://doi.org/10.1007/s00198-006-0172-4

4. Papaioannou A., Kennedy C.C., Ioannidis G. et al. The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2008; 19: 581-587. https://doi.org/10.1007/s00198-007-0483-0

5. Lesnyak O., Ershova O., Belova K., et al. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos. 2012; 7 (1-2): 67-73. https://doi.org/10.1007/s11657-012-0082-3

6. Kanis J.A., Johnell O., De Laet C., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004; 35 (2): 375382. https://doi.org/10.1016/j.bone.2004.03.024

7. Klotzbuecher C.M., Ross P.D., Landsman P.B., Abbott 3rd T.A., Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000; 15 (4): 721-739. https://doi.org/10.1359/jbmr.2000.15.4.721

8. Port L., Center J., Briffa N.K. et al. Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int. 2003; 14 (9): 780-784. https://doi.org/10.1007/s00198-003-1452-x

9. McLellan A., Reid D., Forbes K. et al. Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland (CEPS 99/03). NHS Quality Improvement Scotland. 2004.

10. Edwards B.J., Bunta A.D., Simonelli C., Bolander M., Fitzpatrick L.A. Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res. 2007; 461: 226-230. https://doi.org/10.1097/blo.0b013e3180534269

11. Wells G.A., Cranney A., Peterson J., et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008; (1): CD001155. https://doi.org/10.1002/14651858.cd001155.pub2

12. Palacios S., Kalouche-Khalil L., Rizzoli R., et al. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric. 2015; 18(6): 805-12. https://doi.org/10.3109/13697137.2015.1045484

13. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344(19): 1434-41. https://doi.org/10.3171/foc.2001.11.2.8

14. Lyles K.W., Colon-Emeric C.S., Magaziner J.S., et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357(18): 1799-809. https://doi.org/10.1056/nejmoa074941

15. Akesson K., Marsh D., Mitchell P.J. et al.: IOF Fracture Working Group. Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013; 24 (8): 2135-2152. https://doi.org/10.1007/s00198-013-2348-z

16. Hagino H., Sawaguchi T., Endo N., et al. The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int. 2012; 90: 14-21. https://doi.org/10.1007/s00223-011-9545-6

17. Ganda K., Mitchell P.J., Seibel M.J. Chapter 3 — Models of Secondary Fracture Prevention: Systematic Review and Meta-analysis of Outcomes. Secondary Fracture Prevention. An International Perspective. 2019. P. 33-62. https://doi.org/10.1016/b978-0-12-813136-7.00003-x

18. Marsh D., Akesson K., Beaton D.E. et al. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int. 2011; 22: 2051-2065. https://doi.org/10.1007/s00198-011-1642-x

19. Eisman J.A., Bogoch E.R., Dell R., et al.. Making the first fracture the last fracture: ASBMR Task Force on Secondary Fracture Prevention. J Bone Miner Res. 2012 Oct; 27(10): 2039-46. https://doi.org/10.1002/jbmr.1698

20. International Osteoporosis Foundation. Capture the Fracture: a global campaign to break the fragility fracture cycle — 2012 // International Osteoporosis Foundation: сайт. — Режим доступа: https://www.iofbonehealth.org/capture-fracture-report-2012. — Загл. с экрана.

21. International Osteoporosis Foundation. Capture the Fracture: break the worldwide fragility fracture cycle — 2012 // International Osteoporosis Foundation: сайт. — Режим доступа: https://www.iofbonehealth.org/capture-fracture. — Загл. с экрана

22. Sale J.E., Beaton D., Posen J., et al. Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int. 2011; 22: 2067-2082. https://doi.org/10.1007/s00198-011-1544-y

23. Dell R. Fracture prevention in Kaiser Permanente Southern California. Osteoporos Int. 2011; 22 Suppl 3: 457-60. https://doi.org/10.1007/s00198-011-1712-0

24. Lih A., Nandapalan H., Kim M., et al. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int. 2011; 22(3): 849-58. https://doi.org/10.1007/s00198-010-1477-x

25. Huntjens K.M., van Geel T.A., van den Bergh J.P., et al. Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am. 2014; 96(4): e29. https://doi.org/10.2106/jbjs.l.00223

26. Van der Kallen J., Giles M., Cooper K., et al. A fracture prevention service reduces further fractures two years after incident minimal trauma fracture. Int J Rheum Dis. 2014; 17(2): 195-203 https://doi.org/10.1111/1756-185x.12101

27. Olenginski T.P., Maloney-Saxon G., Matzko C.K., et al. High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach. Osteoporos Int. 2015; 26(2): 801-10 https://doi.org/10.1007/s00198-014-2967-z

28. Ganda K., Schaffer A., Pearson S., Seibel M.J. Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int. 2014; 25 (4): 1345-1355. https://doi.org/10.1007/s00198-013-2610-4

29. Little E.A., Eccles M.P. A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement. Sci. 2010; 5: 80. https://doi.org/10.1186/1748-5908-5-80

30. Javaid M.K., Sami A., Lems W. et al. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporosis International. 2020; 31: 1193-1204. https://doi.org/10.1007/s00198-020-05377-1

31. Gittoes N., McLellan A.R., Cooper A. et al. Effective Secondary Prevention of Fragility Fractures: Clinical Standards for Fracture Liaison Services. Camerton: National Osteoporosis Society. 2015.

32. Shipman K.E., Stammers J., Doyle A., Gittoes N. Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable? Osteoporos Int. 2016. https://doi.org/10.1007/s00198-016-3639-y

33. Royal College of Physicians Falls and Fragility Fracture Audit Programme. Fracture Liaison Service Database (FLS-DB) facilities audit. FLS breakpoint: opportunities for improving patient care following a fragility fracture. London: 2016.

34. Gallacher S., Alexander S., Beswetherick Will Carr N. et al. Effective Secondary Prevention of Fragility Fractures: Clinical Standards for Fracture Liaison Services. Royal Osteoporosis Society. 2019.

35. National Institute for Health and Clinical Excellence. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: NICE Technology Appraisal Guidance 161. 2010.

36. Mel'nichenko GA, Belaya ZhE, Rozhinskaya LYа s soavt. Federal'nye klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike osteoporoza. Problemy Endokrinologii, 2017; 63 (6): 392-426 https://doi.org/10.14341/probl2017636392-426